We are live on ! Find out more
PGEN icon

Precigen

167 hedge funds and large institutions have $690M invested in Precigen in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 46 increasing their positions, 48 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $11.4M

0.58% more ownership

Funds ownership: 76.84%77.42% (+0.58%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less capital invested

Capital invested by funds: $712M → $690M (-$22.3M)

4% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 48

7% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 29

2% less funds holding

Funds holding: 170167 (-3)

Holders
167
Holders Change
-3
Holders Change %
-1.76%
% of All Funds
3.29%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
46
Reduced
48
Closed
29
Calls
$16.2M
Puts
$11.4M
Net Calls
+$4.78M
Net Calls Change
+$1.21M
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$414M +$2.99M +531,655 +0.7%
MVP
2
Miller Value Partners
Florida
$46.1M +$15.2K +2,700 +0%
Vanguard Group
3
Vanguard Group
Pennsylvania
$42.1M +$3.19M +567,494 +8%
BlackRock
4
BlackRock
New York
$38M -$2.57M -456,879 -6%
State Street
5
State Street
Massachusetts
$20.2M -$3.83M -680,826 -16%
NAMA
6
Nikko Asset Management Americas
New York
$17.1M -$428K -76,003 -2%
Sumitomo Mitsui Trust Group
7
Sumitomo Mitsui Trust Group
Japan
$17.1M -$428K -76,003 -2%
Jacobs Levy Equity Management
8
Jacobs Levy Equity Management
New Jersey
$5.95M +$6.11M +1,086,040 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$5.89M +$67.7K +12,031 +1%
Northern Trust
10
Northern Trust
Illinois
$5.26M +$323K +57,351 +6%
MP
11
MSD Partners
New York
$4.93M -$563K -100,000 -10%
FWC
12
First Washington Corp
Washington
$4.83M -$115K -20,353 -2%
Millennium Management
13
Millennium Management
New York
$4.5M +$3.69M +655,535 +396%
First Eagle Investment Management
14
First Eagle Investment Management
New York
$4.48M -$145K -25,847 -3%
Morgan Stanley
15
Morgan Stanley
New York
$4.07M -$642K -113,986 -13%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$3.48M -$139K -24,670 -4%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$2.69M +$2.41M +429,039 +701%
Axa
18
Axa
France
$2.62M +$886K +157,400 +49%
Charles Schwab
19
Charles Schwab
California
$2.41M +$66.3K +11,781 +3%
Two Sigma Investments
20
Two Sigma Investments
New York
$1.81M +$1.1M +195,030 +144%
AIM
21
ARK Investment Management
Florida
$1.78M +$815K +144,807 +80%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.75M +$11.4K +2,024 +0.6%
Goldman Sachs
23
Goldman Sachs
New York
$1.71M -$173K -30,812 -9%
Norges Bank
24
Norges Bank
Norway
$1.69M
N
25
Nuveen
North Carolina
$1.68M +$81.3K +14,450 +5%

PGEN Hedge Fund Activity: Q4 2019 in Review

167 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q4 2019, worth a combined $690M — down 3.1% from $712M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of PGEN and 27 opened new positions — a net loss of 2 holders — while 48 trimmed existing stakes and 46 added.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $6.11M. The largest seller was GMT Capital, exiting entirely with an estimated $3.86M sold.

  • 167 institutional investors held Precigen (PGEN) as of Q4 2019, down from 170 in Q3 2019.
  • Funds reported $690M of Precigen stock for Q4 2019, down 3.1% quarter-over-quarter.
  • 27 funds opened new Precigen positions in Q4 2019 and 29 closed out, a net change of -2 holders.
  • The largest Precigen buyer in Q4 2019 was Jacobs Levy Equity Management, an estimated $6.11M added.
  • The largest Precigen seller in Q4 2019 was GMT Capital, an estimated $3.86M sold.

Based on aggregated 13F filings for Q4 2019.